Takamichi Baba

5PUBLICATIONS
14CO-AUTHORS
Biomolecular modelling and designPharmacogenomicsVirologyEpidemiological modellingPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 15, 2026
Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the RSV L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection.

|Feb 23, 2026
Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial.

Masaki Kato, Kazuyuki Nakagome, Takamichi Baba

|Dec 17, 2024
Stability of Respiratory Syncytial Virus in Nasal Aspirate From Patients Infected With RSV.

Atsuko Yamamoto, Yoko Hayasaki-Kajiwara, Takamichi Baba

|Oct 07, 2024
Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19.

Daichi Yamaguchi, Masaya M Saito, Ayano Hata

|May 06, 2024
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.

Hideyuki Ikematsu, Takamichi Baba, Masaya M Saito

Pageof 1

Frequent Collaborators

1 joint publications

Daichi Yamaguchi

1 joint publications

Masaya M Saito

1 joint publications

Ryosuke Shimizu

1 joint publications

Shogo Miyazawa